Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUMATRIPTAN vs SUTIMLIMAB-JOME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SUMATRIPTAN vs SUTIMLIMAB-JOME: Safety Overview

Metric SUMATRIPTAN SUTIMLIMAB-JOME
Total FAERS Reports 17,442 209
Deaths Reported 305 28
Death Rate 1.7% 13.4%
Hospitalizations 1,580 37
Average Patient Age 45.7 yrs 72.1 yrs
% Female Patients 84.9% 69.9%
FDA Approval Date Apr 14, 2014 N/A
Manufacturer Sun Pharmaceutical Industries, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued Prescription